Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 27(44): 12012-24, 2007 Oct 31.
Article in English | MEDLINE | ID: mdl-17978043

ABSTRACT

Germinal matrix (GM) is a richly vascularized collection of neuronal-glial precursor cells in the developing brain, which is selectively vulnerable to hemorrhage in premature infants. It has rapid angiogenesis associated with high levels of vascular endothelial growth factor (VEGF). Because pericytes provide structural stability to blood vessels, we asked whether pericytes were fewer in the GM than in the subjacent white matter and neocortex and, if so, whether angiogenic inhibition could increase the pericyte density in the GM. We found pericyte coverage and density less in the GM vasculature than in the cortex or white matter in human fetuses, premature infants, and premature rabbit pups. Notably, although VEGF suppression significantly enhanced pericyte coverage in the GM, it remained less than in other brain regions. Therefore, to further elucidate the basis of fewer pericytes in the GM vasculature, we examined expression of ligand-receptor systems responsible for pericyte recruitment. Transforming growth factor-beta1 (TGF-beta1) protein expression was lower, whereas sphingosine-1-phosphate1 (S1P1) and N-cadherin levels were higher in the GM than in the cortex or white matter. Low TGF-beta1 may be involved in promoting endothelial proliferation, whereas elevated S1P1 with N-cadherin may assist vascular maturation. Hence, a paucity of pericytes in the GM vasculature may contribute to its propensity to hemorrhage, and a lower expression of TGF-beta1 could be a basis of reduced pericyte density in its vasculature.


Subject(s)
Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Pericytes/cytology , Premature Birth/pathology , Animals , Antigens/metabolism , Antigens, CD34/metabolism , Autopsy/methods , Blood-Brain Barrier , Cadherins/metabolism , Cerebral Cortex/embryology , Female , Fetus , Gestational Age , Humans , Infant, Newborn , Lysophospholipids/metabolism , Pericytes/metabolism , Pericytes/ultrastructure , Piperidines/pharmacology , Pregnancy/drug effects , Proteoglycans/metabolism , Quinazolines/pharmacology , Rabbits , Sphingosine/analogs & derivatives , Sphingosine/metabolism , Time Factors , Transforming Growth Factor beta1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...